Medical Ceramics Produce Time-Consuming Processes and Expensive Clinical Trials

The rising incidence of age-related disorders (such as rheumatoid arthritis, osteoarthritis, osteoporosis and fractures) and sports injuries drive the demand of knee and hip replacement procedures worldwide. According to the WHO, osteoarthritis will be the world’s fourth-leading cause of disabilities by 2020. According to the American Academy of Orthopedic Surgeons (AAOS), by 2030, ~3.5 million knee replacement procedures will be performed annually in the US. Also, by 2030, it is estimated that more than 570,000 primary total hip replacement procedures will be performed annually in the US.

According to the Lancet Commission on Global Surgery, ~ 2.2 million more surgeons, anesthetics, and obstetricians are required annually in low- and – middle-income countries (LMICs). Also, major healthcare markets such as the US , Germany, and the UK are witnessing a shortage of surgeons in their healthcare systems.

For More Info, Download PDF Brochure @ https://tinyurl.com/4rfarefs

On the basis of type, the global bioactive ceramics market is broadly segmented into hydroxyapatite and glass ceramics. The hydroxyapatite segment accounted for the largest share of the global bioactive ceramics market in 2021. The market growth can be attributed to growing demand of medical implants, and growing plastic surgery & dental care industry.

The medical ceramics market is fragmented and competitive, with a large number of players dominating different product segments, depending on their core competencies. In 2021, the global medical ceramics market was dominated by CoorsTek, Inc. (US), CeramTec GmbH (Germany), KYOCERA Corporation (Japan), Morgan Advanced Materials (UK), Tosoh Corporation (Japan), Institut Straumann AG (Switzerland), 3M (US), and Royal DSM (DSM) (Netherlands).

The players adopted key strategies, such as, collaborations, partnerships, acquisitions, expansions, and product launches to increase their market penetration. .